Activation of p53 Gene Expression in Premalignant Lesions during Head and Neck Ttomorigenesis

Cancer Research

Volumn 54, Issue 2, 1994, Pages 321-326

  Shin, Dong M ^a   Hong, Waun K ^a   Kim, Jhingook ^a   Roth, Jack A ^a   Surgery, Thoracic ^a   Ro, Jae Y ^a   Hittelman, Jason ^a   Hittelman, Walter N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TUMOR MARKER;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE ACTIVATION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MOUTH MUCOSA; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0028158007     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Slaughter, D.L., Southwick, H.W., and Smejkal, W. “Field cancerization” in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer (Phila.), 6: 963-968, 1953.
2. Knudson, A.G. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res., 45: 1437-1443, 1985.
3. Vogelstein, B., Fearon, E.R., Hamilton, S.R., Kern, S.E., Presinger, A.C., Leppert, M., Nakamura, Y., White, R., Smits, A.M.M., and Bos, J.L. Genetic alterations during colorectal tumor development. N. Engl. J. Med., 319: 523-532, 1988.
4. Minna, J.D., Battey, J.R., Brooks, B.J., Cuttitta, F., Garza, A.R., Johnson, B.E., Ihde, D.C., LeBacq-Ver Heyden, A.M., Mulshine, J., Man, M.M., Oie, K.K., Sausville, E.A., Seifter, E., and Vinocour, M. Molecular genetic analysis reveals chromosomal deletion, gene amplification and autocrine growth factor production in the pathogenesis of human lung cancer. Cold Spring Harbor Symp. Quant. Biol., 51: 843-853, 1986.
5. Incze, J., Vaughan, C.W., Lui, R., Strong, M.S., and Kulapaditharom, B. Premalignant changes in normal appearing epithelium in patients with squamous cell carcinomas of the upper aerodigestive tract. Am. J. Surg., 144: 401-105, 1982.
6. Rabinovitch, P.S., Reid, B.J., Haggitt, R.C., Norwood, T.H., Rubin, C.E. Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab. Invest., 60: 65-71, 1988.
7. Silverman, S., Gorsky, M., and Lozada, F. Oral leukoplakia and malignant transformation: a follow-up of 257 patients. Cancer (Phila.), 53: 563-568, 1984.
8. Freinmesser, R., Freeman, J.L., and Noyek, A. Flow cytometric analysis of DNA content in laryngeal cancer. J. Laryngol. Otol., 704; 485-489, 1990.
9. Roa, E.A., Carey, T.E., Passamani, P.P., Greenwood, J.H., Hsu, S., Ridings, E.O., Schwartz, D.R., Wolf, G.T., and Hudson, J.L. DNA content of human squamous cell carcinoma cell lines. Arch. Otolaryngol., Ill: 565-575, 1985.
10. Osella, P., Carlson, A., Wyandt, H., and Milungky, A. Cytogenetic studies of eight squamous cell carcinomas of the head and neck. Deletion of 7q, a possible primary chromosomal event. Cancer Genet. Cytogenet., 59: 73-78, 1992.
11. Tessier, J.R. The chromosomal analysis of human solid tumors: a triple challenge. Cancer Genet. Cytogenet., 37: 103-125, 1989.
12. Oshimura, M., Fitzgerald, D.J., Kitamura, H., Nettesheim, P., and Barrett, J.C. Cytogenetic changes in rat tracheal epithelial cells during early stages of carcinogen induced neoplastic progression. Cancer Res., 48: 702-708, 1988.
13. Nigro, J.M., Baker, S.J., Pressinger, A.C., Jessup, J.M., Hostetter, R., Cleary, K., Bigner, S.H., Davidson, N., Bayin, S., Devilee, P., Glover, T., Collins, R S., Weston, A., Modali, R., Harris, C.C., and Vogelstein, B. Mutations in the p. 3 gene occur in diverse human tumor types. Nature (Lond.), 342: 705-708, 1989.
14. Casson, A.G., Mukhopadhay, T., Cleary, K.G., Ro, J.Y., Levin, B., and Roth, J.A. p. 3 gene mutation in Barrett's epithelium and esophageal cancer. Cancer Res., 57: 4495-4499, 1991.
15. Takahasi, T., Suzuki, H., Hida, T., Sekido, Y., Ariyoshi, Y., and Ueda, R. Thep. 3 gene is very frequently mutated in small cell lung cancer with a distinct nucleotide substitution pattern. Oncogene, 6: 1775-1778, 1991.
16. Baker, S.J., Fearon, S.R., Nigro, J.M., Hamilton, S.R., Presinger, A.C., Jessup, J.M., Van Tuinen, P., Ledbetter, D.H., Baker, D.R., Nakamura, Y., White, R., Vogelstein, B. Chromosome deletions and p. 3 gene mutation in colorectal carcinomas. Science (Washington DC), 244: 217-221, 1989.
17. Brachman, D.G., Graves, D., Vokes, E., Beckett, M., Haraf, D., Montag, A., Dunphy, E., Mick, R., Yandell, D., and Weichselbaum, R.R. Occurrence of p. 3 gene deletion and human papilloma virus infection in head and neck cancer. Cancer Res., 52: 4832-4836, 1992.
18. Gusterson, B.A., Anbazhagan, R., Warren, W., Midgely, C., Lane, D.P., O'Hare, M., Stamps, A., Carter, R., and Jayatilake, H. Expression of p. 3 in premalignant and malignant squamous epithelium. Oncogene, 6: 1785-1789, 1991.
19. Field, J.K., Spandidos, S.A., Malliri, A., Gosney, J.R., Yiagnisis, M., and Stell, P.M. Elevated p. 3 expression correlates with a history of heavy smoking in squamous cell carcinomas of the head and neck, Br. J. Cancer, 64: 573-577, 1991.
20. Cotran, R.S., Kumar, V., and Robbins, S.L. Cellular injury and adaptation. In: R.S. Cotran, V. Kumar, and S.L. Robbins (eds.), Robbins Pathologic Basis of Disease, Ed. 4, pp. 32-35. Philadelphia: W B. Saunders Co., 1989.
21. Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasikimhi, O., and Oren, M. Wild-type p. 3 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA, 86: 8763-8767, 1989.
22. Gown, A.M., and Vogel, A.M. Monoclonal antibodies to human intermediate filament protein II. Distribution of filament protein in normal tissues. Am. J. Pathol., 774: 309-321, 1984.
23. Hollstein, M., Metcalf, R.A., Welsh, J.A., Montasano, R., and Harris, C.C. Frequent mutation of the p. 3 gene in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 87: 9958-9961, 1990.
24. Mazars, R., Pujel, P., Maudelonde, T., Jeanteur, P., Theillet, C. p. 3 mutations in ovarian cancer: a late event? Oncogene, 6: 1685-1690, 1991.
25. Ito, T., Seyama, X., Nakamura, N., and Akiyama, M. Unique association of p. 3 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res., 52: 1369-1371, 1992.
26. Bennett, W.P., Hollstein, M.C., Metcalf, M.A., Welsh, J.A., He, A., Zhu, S.M., Kusters, I., Resau, J.H., Trump, B.R., Lane, D.P., and Harris, C.C.p. 3 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res., 52: 6092-6097, 1992.
27. Sozzi, G., Miozzo, M., Donghi, R., Pilotti, S., Cariani, C.T., Pastorino, U., Porta, G.D., and Pierotti, M.A. Deletions of 17p and p. 3 mutations in preneoplastic lesions of the lung. Cancer Res., 52: 1-, 1992.
28. Nees, M., Homann, N., Discher, H., Andl, T., Enders, C., Harrold-Mende, C., Schulmann, A., and Bosch, F.X. Expression of mutated p. 3 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res., 53: 4189-4196, 1993.
29. Weinert, T., and Lydall, D. Cell cycle check points, genetic instability and cancer. Semin. Cancer Biol., 4: 129-140, 1993.
30. Voravud, N., Shin, D.M., Ro, J.Y., Lee, J.S., Hong, W.K., and Hittelman, W.N. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res., 53: 2874-2883, 1993.
31. Shin, D.M., Voravud, N., Ro, J.Y., Lee, J.S., Hong, W.K., and Hittelman, W.N. Sequential upregulation of proliferating cell nuclear antigen in head and neck tumorigenesis: a potential biomarker. J. Natl. Cancer Inst., 85: 971-978, 1993.